Published results on the Roche Clinical Trials for CLEMATIS expected in the first half of 2019
Many of you have asked LuMind RDS about the publishing of the results of the Hoffman-La Roche (Roche) trials that took place
July 5, 2018
Many of you have asked LuMind RDS about the publishing of the results of the Hoffman-La Roche (Roche) trials that took place
Patients with Down syndrome are at risk of atlantoaxial instability (AAI). Although AAI can occur in other conditions, such as
Parents and caregivers often get in touch because they have heard that that everyone with Down syndrome will develop Alzheimer’s
Alzheimer’s disease (AD) may affect in excess of 90% of individuals with Down syndrome (DS) after age 60, due to
In this video, Stephanie L. Santoro, M.D. discusses health care for adults with Down syndrome. Source: Massachusetts Down Syndrome Congress
The aim of this study was to investigate cancer incidence in a large cohort of persons with Down syndrome.Source: Henrik
The aim of this study was to examine whether the presence of pain (based on physical conditions and participants’ report)
The aim of this study was to describe the incidence of morbidities and the prevalence of medical prescriptions in a
Down syndrome (DS) is associated with a higher incidence of many medical conditions, but little information regarding urinary retention exists.
Purpose of Review: To review clinical updates and current healthcare issues for adolescents with Down syndrome and intellectual disabilities, including